Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for LATUDA
- 18F-DOPA PET to Elucidate the Antidepressant Mechanism of Lurasidone in Bipolar Disorder
- A Study to Assess the Safety and Efficacy of ASP4345 as Add-on Treatment for Cognitive Impairment in Subjects With Schizophrenia on Stable Doses of Antipsychotic Medication
- A Study of Lurasidone HCl in Subjects With Schizophrenia
- Study of the Efficacy of Lurasidone in Cognitive Functioning in Bipolar Patients
- Biosignatures of Latuda for Bipolar Depression
- Lurasidone Effects on Tissue Glutamate in Schizophrenia
- Lurasidone and Cognition in Bipolar I Disorder
- Lurasidone Pediatric Bipolar Study
- A Clinical Trial of Lurasidone in Treatment of Schizophrenia
- Open-Label Study of Latuda for the Treatment of Mania in Children and Adolescents 6-17 Years Old
- Pediatric Open-Label Extension Study
- Lurasidone Pediatric Autism Study
- Pediatric Schizophrenia Efficacy and Safety Study
- Lurasidone Low-Dose - High-Dose Study Study
- Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents
- Lurasidone Pediatric Pharmacokinetics Study
- High Dose Lurasidone for Patients With Treatment Resistant Schizophrenia
- PEARL Schizophrenia Maintenance
- Major Depressive Disorder With Mixed Features - Extension
- Major Depressive Disorder With Mixed Features
- Major Depressive Disorder (MDD) With Mixed Features - Flexible Dose
- Lurasidone HCI - A 6-week Phase 3 Study of Patients With Bipolar I Depression
- A Study Evaluating Lurasidone for The Treatment of Schizophrenia or Schizoaffective Disorder in Subjects Switched From Other Antipsychotic Agents
- Omega-3 Fatty Acids (Lovaza) for Second Generation Antipsychotic-Associated Hypertriglyceridemia
Clinical trials list
click for details